Scientists suggest near-infrared-triggered nanozyme-mediated synergistic cascade tumor therapy

16 Sep 2022
Scientists suggest near-infrared-triggered nanozyme-mediated synergistic cascade tumor therapy

In a paper published on ACS Applied Materials & Interfaces recently, a collaborated research team led by Prof. WANG Hui and Prof. ZHANG Xin from High Magnetic Field Laboratory as well as Prof. QIAN Junchao from Institute of Health and Medical Technology, Hefei Institutes of Physical Science (HFIPS) of Chinese Academy of Sciences (CAS) reported a new kind of near-infrared-triggered nanozyme based on iron oxide nanocrystals embedded in N-doped carbon nanosheets (IONCNs) through a solvothermal route and their significant application prospects in synergistic cascade tumour therapy.

Chemodynamic therapy (CDT) was an efficient cancer treatment method determined by the striking difference between the tumour microenvironments (TMEs) and normal tissues.

By triggering the Fenton or Fenton-like reaction, it could generate highly toxic hydroxyl radical (·OH) to achieve the killing of tumor cells.

Unfortunately, the overexpression of glutathione (GSH) in TMEs limited the therapeutic efficacy by counteracting ·OH generation.

Moreover, the normal cells or inflammatory cells were easily affected simultaneously owing to their similar characteristics to the TMEs.

Therefore, it was necessary to develop an exogenous triggered nanozyme to realise tumour-specific catalytic therapy.

In this research, researchers used a one-step hydrothermal method to synthesise IONCNs.

The as-prepared IONCNs could absorb and convert 980 nm light to local heat that not only killed cancer cell by photothermal therapy but also induced the dissolution of iron oxide to produce Fe2+/Fe3+ in a weak acid solution.

The formed Fe2+ catalysed the decomposition of hydrogen peroxide to generate hydroxyl radical for CDT.

The formed Fe3+ acted as a glutathione peroxidase to amplify the oxidative stress of cancer cells and therapeutic effect of CDT.

Additionally, the IONCNs could be used as a magnetic resonance imaging contrast agent to visually monitor the treatment process of cancer.

Source: Hefei Institutes of Physical Science, Chinese Academy of Sciences